Nobel Biocare Expands Grafting Options by Launching Membrane Line Based on Synthetic Technology
Nobel Biocare has partnered with the synthetic membrane market leader and launched creos™ syntoprotect, a new line of dense PTFE membranes, expanding its portfolio of regenerative products.
creosTM syntoprotect joins xenoprotect, allo.gain, allo.protect, xenogain and wound dressing to establish Nobel Biocare as the supplier of choice for natural or synthetic regeneration need.
Nobel Biocare has partnered with the synthetic membrane market leader and launched a new line of dense PTFE membranes, expanding its portfolio of regenerative products. The move allows Nobel Biocare and its family of carefully-designed regeneration solutions – creos – to take a decisive step towards meeting the ever-diverse needs of dental professionals.
The creos™ syntoprotect dense PTFE membranes are designed to withstand exposure to the oral cavity for extraction socket management when primary closure is not possible. The line also offers 13 shapes of titanium-reinforced dense PTFE membranes for ridge augmentations and grafting large osseous defects.
By launching syntoprotect, Nobel Biocare is bringing to market a new solution that is based on an established technology with more than 25 years of clinical practice.
The 13 titanium-reinforced membrane options are easy to trim and versatile in shaping and positioning.
creos™ syntoprotect is now available in Europe and the United States, where the line of creos regenerative products is conveniently available from the Nobel Biocare online store or through any Nobel Biocare sales representative.
For more information on creos™ and the new creos™ syntoprotect, dental professionals can visit nobelbiocare.com/creos or contact their local sales representative.
